- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
Patent holdings for IPC class A61K 31/593
Total number of patents in this class: 1287
10-year publication summary
140
|
117
|
131
|
136
|
129
|
143
|
181
|
150
|
120
|
60
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Wisconsin Alumni Research Foundation | 3874 |
43 |
DSM IP Assets B.V. | 5595 |
40 |
EirGen Pharma Limited | 88 |
40 |
Société des Produits Nestlé S.A. | 9269 |
36 |
LEO Pharma A/S | 433 |
17 |
N.V. Nutricia | 1062 |
15 |
Journey Medical Corporation | 94 |
13 |
AMBO Innovations, LLC | 29 |
11 |
Opko Ireland Global Holdings, Ltd. | 19 |
11 |
Nulixir Inc. | 39 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
10 |
Nestec S.A. | 2669 |
9 |
Ldn Pharma Limited | 42 |
9 |
The Trustees of the University of Pennsylvania | 4317 |
8 |
Albert Einstein College of Medicine, Inc. | 576 |
8 |
Matthias W. Rath | 24 |
8 |
URGO Recherche Innovation et Developpement | 298 |
8 |
Nutri Co., Ltd. | 48 |
7 |
Massachusetts Institute of Technology | 10041 |
6 |
Opko Renal, LLC | 8 |
6 |
Other owners | 971 |